Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis

Volume: 29, Issue: 5, Pages: 779 - 792
Published: Nov 25, 2021
Abstract
Lipoprotein(a) [Lp(a)] is a causal and independent risk factor for cardiovascular disease (CVD). People with elevated Lp(a) are often prescribed statins as they also often show elevated low-density lipoprotein cholesterol (LDL-C) levels. While statins are well-established in lowering LDL-C, their effect on Lp(a) remains unclear. We evaluated the effect of statins compared to placebo on Lp(a) and the effects of different types and intensities of...
Paper Details
Title
Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis
Published Date
Nov 25, 2021
Volume
29
Issue
5
Pages
779 - 792
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.